Insurers

For insurers, KINsight functions as risk-management infrastructure. Early identification of inherited cancer risk reduces late-stage cancer incidence, lowers catastrophic claim frequency, reduces claims against costs already provisioned by actuaries, and stabilises long-term loss ratios. By addressing correlated family risk upstream, KINsight reduces claims volatility, improves pricing confidence, and strengthens long-term portfolio performance across Life, PMI, and Critical Illness products.

KINsight enables insurers to act on cancers whose costs their actuaries will already have priced in and they already expect to pay – saving lives and delivering material cost savings without adding unbudgeted spend.